Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atara Biotherapeutics

7.60
+0.700010.14%
Post-market: 7.600.00000.00%18:35 EDT
Volume:56.69K
Turnover:421.78K
Market Cap:44.53M
PE:-0.67
High:7.76
Open:6.97
Low:6.94
Close:6.90
Loading ...

BRIEF-Atara Biotherapeutics Inc - On March 31, Entered Amendment To Commercialization Agreement With Pierre Fabre - SEC Filing

Reuters
·
05 Apr

Atara Biotherapeutics Inc - Pierre Fabre to Assume Costs for FDA Remediation to Support Bla Resubmission for Tab-Cel - SEC Filing

THOMSON REUTERS
·
05 Apr

Atara Biotherapeutics Inc - Bio to Receive up to $550 Mln in Milestone Payments - SEC Filing

THOMSON REUTERS
·
05 Apr

Atara Biotherapeutics Inc - on March 31, Entered Amendment to Commercialization Agreement With Pierre Fabre - SEC Filing

THOMSON REUTERS
·
05 Apr

BRIEF-Atara Biotherapeutics Inc - Eric Hyllengren To Step Down As CFO And COO Of Atara Biotherapeutics - SEC Filing

Reuters
·
01 Apr

Atara Biotherapeutics Inc - Eric Hyllengren to Step Down as CFO and COO of Atara Biotherapeutics - SEC Filing

THOMSON REUTERS
·
01 Apr

Atara Biotherapeutics: Strategic Focus on Ebvallo BLA Resubmission and Market Position Enhancement

TIPRANKS
·
11 Mar

Atara Biotherapeutics Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
11 Mar

Atara Biotherapeutics (ATRA) Receives a Buy from TD Cowen

TIPRANKS
·
10 Mar

Atara Biotherapeutics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
09 Mar

Atara Biotherapeutics Faces Potential Liquidation: Strategic Decisions Crucial for Investor Outcomes

TIPRANKS
·
09 Mar

Atara Biotherapeutics Reports 2024 Financial Results

TIPRANKS
·
08 Mar

Atara Biotherapeutics (ATRA) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
08 Mar

Atara Biotherapeutics to Cut Half of Workforce Amid Restructuring

Dow Jones
·
08 Mar

Atara Biotherapeutics: Q4 Earnings Snapshot

Associated Press Finance
·
08 Mar

Atara Biotherapeutics reports Q4 EPS ($1.19) vs. ($14.00) last year

TIPRANKS
·
08 Mar

Atara Biotherapeutics Q4 2024 GAAP EPS $(1.19) Beats $(3.58) Estimate, Sales $32.753 Miss $19.148M Estimate

Benzinga
·
08 Mar

Atara Biotherapeutics Inc: Strategic Review by Financial Advisor Ongoing

THOMSON REUTERS
·
08 Mar

Atara Biotherapeutics Inc: Implemented a Workforce Reduction of Approximately 50% to Preserve Resources

THOMSON REUTERS
·
08 Mar

Atara Biotherapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Operational Progress

Business Wire
·
08 Mar